Fig. 3
From: Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis
Characterization of circulating fibrocytes in IPF and PH patients. a Representative gating strategy for the detection of circulating fibrocytes (CD45+CD15−Lin−CXCR4+Col-1+-cells) in freshly analyzed PBMCs of heathy controls (n = 5), PH patients (n = 5) and IPF patients (n = 4). The lineage mix includes markers CD3, CD19 and CD56 to exclude T-cells, B-cells and NK-cells. b Representative histogram overlay showing expression levels depicted as MFI of indicated markers assessed with flow cytometry of circulating fibrocytes (red), T cells (gray) and CD14+ monocytes (black)